$LMND

Peters John Sheldon sold $283K of LMND

Peters John Sheldon (Chief Insurance Officer) sold 5,343 shares of Lemonade, Inc. (LMND) at an average of $53.01 ($52.94–$53.17, $0.28M total) across 2 trades over 2026-06-03 to 2026-06-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Peters John Sheldon
Published Jun 5, 2026, 9:33 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 4:00 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LMND
Bearish
medium confidence
Mentioned
$LMND
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LMNDBearishLow
01

Why it matters

The disclosed sale is modest and pre‑arranged, likely resulting in limited price movement.

02

Market read

A routine insider sale with modest value; low immediate trading relevance.

03

What to watch

The insider retains a sizable stake (81,386 shares) indicating continued confidence.

Relevance 3/10Novelty 3/10Timing: post‑filing today

Background

Form 4 filings provide transparent disclosure of insider transactions, used by traders to gauge insider sentiment.

Company-level read

Ticker impact

$LMNDBearishMedium confidence
Context

SEC Form 4 disclosed Chief Insurance Officer Peters John Sheldon sold 5,343 shares for $283,257, a routine insider sale via 10b5‑1 plan.

Expected impact

potential slight downward pressure as the market prices the insider sell

Evidence & confidence

Sale size is modest ($283K) and executed under a pre‑arranged plan, limiting surprise but still a negative signal.

Market effects

Minimal impact on the broader insurtech sector; similar insider sales are common.

Limited to U.S. equity markets where Lemonade trades.

Low; the filing does not affect global market dynamics.

Counterpoint

The sale could be viewed as a routine liquidity move, not a bearish indicator.

Key entities

  • Lemonade, Inc.

    US‑listed insurtech firm (ticker LMND).

  • Peters John Sheldon

    Chief Insurance Officer of Lemonade.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LMNDMed

Most Drivers Are Overpaying. Lemonade CEO Says Two

Lemonade (LMND) CEO Daniel Schreiber claims two-thirds of U.S. drivers overpay for insurance due to flat-rate pricing. The company offers Tesla (TSLA) FSD subscribers a 50% per-mile discount. Q2 revenue rose 79% to $294M, but net loss was $43M. Lemonade targets first positive adjusted EBITDA in Q4 2026. TSLA shares are up 10.6% over the past month.

$LMNDMed

Lemonade Shares Slide After Results Fail to Meet High Investor Expectations

Lemonade, Inc. (NYSE:LMND) shares fell more than 7% in pre-market trading after the AI-powered insurance company released its second-quarter 2026 results, with investors reacting negatively despite revenue outperforming expectations. The sell-off reflected concerns that the company's outlook failed to justify the high expectations already priced into the stock, following a strong rally earlier in the year.

$LMNDMedAI 8/10

Lemonade Crashes As Customer Growth Miss Spooks Wall Street

Lemonade (LMND) shares fell about 18% in early trading after its Q2 customer growth missed Wall Street expectations. Customers rose 23% to 3.31 million versus a 3.33 million estimate. Revenue increased 79% to $294.4 million, adjusted EBITDA loss narrowed to $18.7 million, and gross loss ratio improved to 60%. Lemonade also announced a CFO transition.